Driving forces and potential risks of the tide of "anti-tumor drug research and development"

SFDA: Starting from March 1, the provincial bureau will stop accepting applications for review and approval of drug technology transfer registration

Work procedures for the verification of drug clinical trial data were released and the first batch of verification lists were announced

Baiyang Pharmaceutical Memantine Hydrochloride Sustained-release Capsules have been approved to benefit domestic Alzheimer's disease patients with international quality

After ten years of hard work, Baiyang Pharmaceutical's Metformin Hydrochloride Sustained Release Tablets (Ⅲ) have been launched in China